Atrial Fibrillation - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Atrial Fibrillation > What Your Doctor is Reading About Atrial Fibrillation > Review Articles

Review Articles

1. Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?

Author: Asirvatham SJ;
Institution
Journal: Circulation. 2007 Nov 27;116(22):2517-9.

2. Management of atrial fibrillation in heart failure in the elderly.

Author: Abi Nasr I; Mansencal N; Dubourg O;
Institution: Cardiology Department, University Hospital Ambroise Pare, Assistance Publique-Hopitaux de Paris, UFR de medecine Paris-Ile-France-Ouest, Faculte de Versailles-Saint-Quentin-en-Yvelines, Boulogne-Billancourt, France. imad.abi-nasr@apr.aphp.fr
Journal: Int J Cardiol. 2008 Apr 10;125(2):178-82. Epub 2007 Oct 29.
Abstract URL: Click here to view abstract

3. Atrial fibrillation: insights from clinical trials and novel treatment options.

Author: Blaauw Y; Crijns HJ;
Institution: Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands.
Journal: J Intern Med. 2007 Dec;262(6):593-614.
Abstract URL: Click here to view abstract

4. Atrial fibrillation and the postoperative cardiac surgery patient.

Author: Palazzo MO;
Institution: The Heart Institute, St. Joseph Medical Center, 7601 Osler Drive, Towson, MD 21204, USA. terripalazzo@chi-east.org
Journal: Crit Care Nurs Clin North Am. 2007 Dec;19(4):395-402, vi.
Abstract URL: Click here to view abstract

5. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.

Author: Savelieva I; Camm J;
Institution: Division of Cardiac and Vascular Sciences, St George's University of London, London, UK.
Journal: Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):30-41.
Abstract URL: Click here to view abstract

6. Is there a link between atrial fibrillation and certain bacterial infections?

Author: Andrew P; Montenero AS;
Institution: aATLAS Medical Research Inc., St Lazare, Quebec, Canada.
Journal: J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):990-6.
Abstract URL: Click here to view abstract

7. New antiarrhythmic treatment of atrial fibrillation.

Author: Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD;
Institution: Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S. Hershey Medical Center, 500 University Dr., Room H 1.511, Hershey, PA 17033, USA. gnaccarelli@psu.edu
Journal: Expert Rev Cardiovasc Ther. 2007 Jul;5(4):707-14.
Abstract URL: Click here to view abstract

8. Percutaneous catheter ablation of atrial fibrillation.

Author: Daoud EG;
Institution: Richard M. Ross Heart Hospital, Division of Cardiology, Ohio State University Medical Center, Columbus, OH, USA. emile.daoud@osumc.edu
Journal: Expert Rev Cardiovasc Ther. 2007 Jul;5(4):693-705.
Abstract URL: Click here to view abstract

9. Ablation should not be first-line therapy for the treatment of atrial fibrillation.

Author: Haigney MC;
Institution: Division of Cardiology, Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, USA. mhaigney@usuhs.edu
Journal: Expert Rev Cardiovasc Ther. 2007 Jul;5(4):673-9.
Abstract URL: Click here to view abstract

10. Catheter ablation as first-line therapy for patients with symptomatic atrial fibrillation.

Author: Chugh A;
Institution: University of Michigan Hospitals, Division of Cardiology, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0311, USA. achugh@umich.edu
Journal: Expert Rev Cardiovasc Ther. 2007 Jul;5(4):663-72.
Abstract URL: Click here to view abstract

11. Catheter ablation of persistent and permanent atrial fibrillation: Bordeaux experience.

Author: Lim KT; Matsuo S; O'Neill MD; Knecht S; Arantes L; Derval N; Jais P; Hocini M; Clementy J; Haissaguerre M;
Institution: Hopital Cardiologique du Haut Leveque, and Universite Victor Segalen Bordeaux II, 33604 Bordeaux, Pessac, France. kangteng1973@yahoo.com
Journal: Expert Rev Cardiovasc Ther. 2007 Jul;5(4):655-62.
Abstract URL: Click here to view abstract

12. Surgical approaches for atrial fibrillation.

Author: Schouchoff B;
Institution: West Penn Allegheny Health System, Allegheny General Hospital, Pittsburgh, Pa, USA. bschouch@wpahs.org
Journal: Crit Care Nurs Q. 2007 Jul-Sep;30(3):233-42; quiz 243-4.
Abstract URL: Click here to view abstract

13. Novel anti-arrhythmic drugs for atrial fibrillation management.

Author: Ehrlich JR; Nattel S; Hohnloser SH;
Institution: Division of Cardiology, Section of Electrophysiology, J.W. Goethe-University, Frankfurt, Germany. j.ehrlich@em.uni-frankfurt.de
Journal: Curr Vasc Pharmacol. 2007 Jul;5(3):185-95.
Abstract URL: Click here to view abstract

14. New pharmacologic approaches to prevent thromboembolism in patients with atrial fibrillation.

Author: Hammwohner M; D'Alessandro A; Wolfram O; Goette A;
Institution: University Hospital Magdeburg, Division of Cardiology, Magdeburg, Germany.
Journal: Curr Vasc Pharmacol. 2007 Jul;5(3):211-9.
Abstract URL: Click here to view abstract

15. Management of atrial fibrillation.

Author: Lip GY; Tse HF;
Institution: University Department of Medicine, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.uk
Journal: Lancet. 2007 Aug 18;370(9587):604-18.
Abstract URL: Click here to view abstract

16. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.

Author: Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ;
Institution: Division of Cardiology, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Journal: Cardiol Rev. 2007 Sep-Oct;15(5):231-41.
Abstract URL: Click here to view abstract

17. Independent predictors of stroke in patients with atrial fibrillation: a systematic review.

Author
Institution: University of Texas Health Science Center, San Antonio, TX 78284, USA.
Journal: Neurology. 2007 Aug 7;69(6):546-54.
Abstract URL: Click here to view abstract

18. The potential role of thiazolidinediones in atrial fibrillation.

Author: Liu T; Korantzopoulos P; Li G; Li J;
Institution
Journal: Int J Cardiol. 2008 Aug 1;128(1):129-30. Epub 2007 Jul 25.
Abstract URL: Click here to view abstract

19. In the clinic. Atrial fibrillation.

Author: Callans DJ;
Institution
Journal: Ann Intern Med. 2008 Nov 4;149(9):ITC5-1-15; quiz ITC5-16.

20. Atrial fibrillation and mitral valve repair.

Author: Jovin A; Oprea DA; Jovin IS; Hashim SW; Clancy JF;
Institution: Harbor Medical Associates, Clinton, Connecticut, USA. isjovin@yahoo.com
Journal: Pacing Clin Electrophysiol. 2008 Aug;31(8):1057-63.
Abstract URL: Click here to view abstract

21. Strategies for primary and secondary stroke prevention in atrial fibrillation.

Author: Finsterer J; Stollberger C;
Institution: Department of Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria. fifigs1@yahoo.de
Journal: Neth J Med. 2008 Sep;66(8):327-33.
Abstract URL: Click here to view abstract

22. Treatment of atrial fibrillation.

Author: Blaauw Y; Crijns HJ;
Institution: Department of Cardiology, Maastricht University Medical Center, Postbus 5800, 6202 AZ Maastricht, The Netherlands.
Journal: Heart. 2008 Oct;94(10):1342-9.

23. Nonpharmacologic strategies: the evolving story of ablation and hybrid therapy.

Author: d'Avila A; Ruskin JN;
Institution: Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. adavila@partners.org
Journal: Am J Cardiol. 2008 Sep 22;102(6A):20H-24H.
Abstract URL: Click here to view abstract

24. Treatment of atrial fibrillation and atrial flutter: Part II.

Author: Aronow WS;
Institution: Department of Medicine, Division of Cardiology, New York Medical College/Westchester Medical Center, Valhalla, New York 10595, USA. wsaronow@aol.com
Journal: Cardiol Rev. 2008 Sep-Oct;16(5):230-9.
Abstract URL: Click here to view abstract

25. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.

Author: Savelieva I; Camm J;
Institution: Division of Cardiac and Vascular Sciences, St George's University of London, Cranmer Terrace, London SW17 0RE, UK. isavelie@sgul.ac.uk
Journal: Europace. 2008 Jun;10(6):647-65.
Abstract URL: Click here to view abstract

26. Pharmacotherapy of atrial fibrillation: an old option with new possibilities.

Author: Janko S; Dorwarth U; Hoffmann E;
Institution: Heart Center Munich-Bogenhausen, Department of Cardiology and Intensive Care Unit, Klinikum Bogenhausen, Stadtisches Klinikum Munchen GmbH, Englschalkinger Strasse 77, 89125 Munich, Germany.
Journal: Expert Opin Pharmacother. 2008 Apr;9(6):913-25.
Abstract URL: Click here to view abstract

27. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review.

Author: Noheria A; Kumar A; Wylie JV Jr; Josephson ME;
Institution: Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Journal: Arch Intern Med. 2008 Mar 24;168(6):581-6.
Abstract URL: Click here to view abstract

28. Atrial fibrillation and Brugada syndrome.

Author: Francis J; Antzelevitch C;
Institution: Department of Cardiology, Calicut Medical College, Calicut, Kerala, India. francisj@cmc.edu.in
Journal: J Am Coll Cardiol. 2008 Mar 25;51(12):1149-53.
Abstract URL: Click here to view abstract

29. Novel non-pharmacological approaches for antiarrhythmic therapy of atrial fibrillation.

Author: Koebe J; Kirchhof P;
Institution: Department of Cardiology and Angiology, University Hospital Munster, Albert-Schweitzer-Str. 33, 48149 Muenster, Germany.
Journal: Europace. 2008 Apr;10(4):433-7. Epub 2008 Mar 12.
Abstract URL: Click here to view abstract

30. Vernakalant in the management of atrial fibrillation.

Author: Cheng JW;
Institution: Massachusetts College of Pharmacy and Health Sciences, Brigham and Women's Hospital, Boston, MA 02115, USA. judy.cheng@mcphs.edu
Journal: Ann Pharmacother. 2008 Apr;42(4):533-42. Epub 2008 Mar 11.
Abstract URL: Click here to view abstract

31. Management of atrial fibrillation in patients with heart failure.

Author: Efremidis M; Pappas L; Sideris A; Filippatos G; Efremidis M; Pappas L; Sideris A; Filippatos G;
Institution: Evangelismos General Hospital of Athens and the Athens University Hospital, Attikon, Athens Greece.
Journal: J Card Fail. 2008 Apr;14(3):232-7.
Abstract URL: Click here to view abstract

32. Update on atrial fibrillation: part II.

Author: Savelieva I; Camm J;
Institution: St. George's University of London, London, UK.
Journal: Clin Cardiol. 2008 Mar;31(3):102-8.
Abstract URL: Click here to view abstract

33. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.

Author: Chiam PT; Ruiz CE;
Institution: Lenox Hill Heart and Vascular Institute of New York, 130 East 77th Street, 9th Floor Blackhall, New York, NY 10075, USA.
Journal: J Invasive Cardiol. 2008 Apr;20(4):E109-13.
Abstract URL: Click here to view abstract

34. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.

Author: Schoonderwoerd BA; Smit MD; Pen L; Van Gelder IC;
Institution: Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.
Journal: Europace. 2008 Jun;10(6):668-73. Epub 2008 May 13.
Abstract URL: Click here to view abstract

35. Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation.

Author: Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Stevenson R; Gonzalez MD;
Institution: Penn State University College of Medicine, Division of Cardiology, 500 University Dr Room H 1.511, Hershey, PA 17033, USA. gnaccarelli@psu.edu
Journal: Expert Opin Investig Drugs. 2008 May;17(5):805-10.
Abstract URL: Click here to view abstract

36. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.

Author
Institution
Journal: Stroke. 2008 Jun;39(6):1901-10. Epub 2008 Apr 17.
Abstract URL: Click here to view abstract

37. Reducing the risk for stroke in patients who have atrial fibrillation.

Author: Garcia DA; Hylek E;
Institution: Department of Internal Medicine, 1 University of New Mexico, MSC10 5550, Albuquerque, NM 87131, USA. davgarcia@salud.unm.edu
Journal: Cardiol Clin. 2008 May;26(2):267-75, vii.
Abstract URL: Click here to view abstract

38. Catheter ablation for atrial fibrillation.

Author: Lubitz SA; Fischer A; Fuster V;
Institution: Zena and Michael A Wiener Cardiovascular Institute, Marie-Josee and Henry R Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, Box 1030, New York, NY 10029, USA. steven.lubitz@mssm.edu
Journal: BMJ. 2008 Apr 12;336(7648):819-26.

39. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.

Author: Garwood CL; Corbett TL;
Institution: Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA. cgarwood@wayne.edu
Journal: Ann Pharmacother. 2008 Apr;42(4):523-32. Epub 2008 Mar 11.
Abstract URL: Click here to view abstract

40. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies.

Author: Baker WL; White CM;
Institution: School of Pharmacy, University of Connecticut, Hartford, CT, USA.
Journal: Ann Pharmacother. 2007 Apr;41(4):587-98. Epub 2007 Mar 20.
Abstract URL: Click here to view abstract

41. Amiodarone for atrial fibrillation.

Author: Zimetbaum P;
Institution: Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. pzimetba@bidmc.harvard.edu
Journal: N Engl J Med. 2007 Mar 1;356(9):935-41.

42. Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent.

Author: Fedida D;
Institution: University of British Columbia, Department of Anesthesiology, Vancouver, British Columbia, Canada.
Journal: Expert Opin Investig Drugs. 2007 Apr;16(4):519-32.
Abstract URL: Click here to view abstract

43. Modern management of atrial fibrillation.

Author: Watson T; Shanstila E; Lip GY;
Institution: University Department of Medicine, City Hospital, Birmingham.
Journal: Clin Med. 2007 Jan-Feb;7(1):28-34.
Abstract URL: Click here to view abstract

44. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.

Author: Strong SH; Halperin JL;
Institution: Kaiser Permanente, USA.
Journal: Geriatrics. 2007 Mar;62(3):22-7.
Abstract URL: Click here to view abstract

45. Postthoracotomy atrial fibrillation.

Author: Amar D;
Institution: Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, USA. amard@mskcc.org
Journal: Curr Opin Anaesthesiol. 2007 Feb;20(1):43-7.
Abstract URL: Click here to view abstract

46. Current strategies in the surgical treatment of atrial fibrillation: review of the literature and Onze Lieve Vrouw Clinic's strategy.

Author: Bakir I; Casselman FP; Brugada P; Geelen P; Wellens F; Degrieck I; Van Praet F; Vermeulen Y; De Geest R; Vanermen H;
Institution: Cardiovascular and Thoracic Surgery Department, Onze Lieve Vrouw Clinic, Aalst, Belgium.
Journal: Ann Thorac Surg. 2007 Jan;83(1):331-40.
Abstract URL: Click here to view abstract

47. Pharmacological therapy of atrial fibrillation.

Author: Patton KK; Page RL;
Institution: University of Washington Medical Center, Division of Cardiology, 1959 NE Pacific Street, Box 356422, Seattle, WA 98122, USA. krpatton@u.washington.edu
Journal: Expert Opin Investig Drugs. 2007 Feb;16(2):169-79.
Abstract URL: Click here to view abstract

48. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.

Author: Onalan O; Crystal E;
Institution: Arrhythmia Services, Division of Cardiology, Sunnybrook Health Science Centre, University of Toronto, Toronto, Canada.
Journal: Stroke. 2007 Feb;38(2 Suppl):624-30.
Abstract URL: Click here to view abstract

49. Advances in surgical treatment of atrial fibrillation.

Author: Gillinov AM;
Institution: Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, OH 44195, USA. gillinom@ccf.org
Journal: Stroke. 2007 Feb;38(2 Suppl):618-23.
Abstract URL: Click here to view abstract

50. Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control.

Author: Sherman DG;
Institution: Division of Neurology/Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA. sherman@uthscsa.edu
Journal: Stroke. 2007 Feb;38(2 Suppl):615-7.
Abstract URL: Click here to view abstract

51. Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation.

Author: Bradley DJ; Shen WK;
Institution: Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Journal: Clin Pharmacol Ther. 2007 Feb;81(2):284-7.
Abstract URL: Click here to view abstract

52. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Author: Calkins H; Brugada J; Packer DL; Cappato R; Chen SA; Crijns HJ; Damiano RJ Jr; Davies DW; Haines DE; Haissaguerre M; Iesaka Y; Jackman W; Jais P; Kottkamp H; Kuck KH; Lindsay BD; Marchlinski FE; McCarthy PM; Mont JL; Morady F; Nademanee K; Natale A; Pappone C; Prystowsky E; Raviele A; Ruskin JN; Shemin RJ;
Institution: Johns Hopkins Hospital, Maryland, USA.
Journal: Heart Rhythm. 2007 Jun;4(6):816-61. Epub 2007 Apr 30.

53. Atrial fibrillation in the elderly.

Author: Fang MC; Chen J; Rich MW;
Institution: Division of General Internal Medicine Hospitalist Group, University of California, San Francisco, CA 94143, USA. mfang@medicine.ucsf.edu
Journal: Am J Med. 2007 Jun;120(6):481-7.
Abstract URL: Click here to view abstract

54. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.

Author: Dale KM; White CM;
Institution: School of Pharmacy, University of Connecticut, Hartford, CT, USA.
Journal: Ann Pharmacother. 2007 Apr;41(4):599-605. Epub 2007 Mar 27.
Abstract URL: Click here to view abstract

55. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis.

Author: Liu T; Li G; Li L; Korantzopoulos P;
Institution: Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Journal: J Am Coll Cardiol. 2007 Apr 17;49(15):1642-8. Epub 2007 Apr 2.
Abstract URL: Click here to view abstract